RATIONALE: HIV-infected persons on antiretroviral therapy (ART) remain at higher risk of pulmonary tuberculosis (TB) than HIV-uninfected individuals. This increased susceptibility may be caused by impairment of alveolar macrophage (AM) function and/or mycobacteria-specific alveolar CD4(+) T-cell responses observed in HIV-infected ART-naive adults. OBJECTIVES: To determine whether ART was associated with improvement in both AM function, assessed by phagosomal proteolysis, and alveolar CD4(+) T-cell responses to Mycobacterium in HIV-infected individuals. METHODS: Peripheral blood was drawn and bronchoalveolar lavage (BAL) performed on healthy, 35 HIV-uninfected, 25 HIV-infected ART-naive, and 50 HIV-infected ART-treated asymptomatic adults. Phagosomal proteolysis of AM was assessed with fluorogenic beads. Mycobacteria-specific CD4(+) T-cell responses were measured by intracellular cytokine staining. MEASUREMENTS AND MAIN RESULTS: HIV-infected adults on ART exhibited lower plasma HIV viral load and higher blood CD4(+) T-cell count than ART-naive adults. AM proteolysis and total mycobacteria-specific Th1 CD4(+) T-cell responses in individuals on ART for greater than or equal to 4 years were similar to HIV-uninfected control subjects but those on ART for less than 4 years had impaired responses. Total influenza-specific alveolar Th1 CD4(+) T-cell responses were intact in all individuals receiving ART. In contrast, BAL and blood mycobacteria-specific polyfunctional CD4(+) T-cell responses were impaired in adults on ART irrespective of duration. CONCLUSIONS: AM and mycobacteria-specific alveolar CD4(+) T-cell responses in HIV-infected adults on ART for less than 4 years are impaired and may partly explain the high risk of TB in HIV-infected individuals on ART. Strategies to augment ART to improve lung immune cell function and reduce the high incidence of TB in HIV-infected adults who initiate ART should be investigated.
RATIONALE: HIV-infectedpersons on antiretroviral therapy (ART) remain at higher risk of pulmonary tuberculosis (TB) than HIV-uninfected individuals. This increased susceptibility may be caused by impairment of alveolar macrophage (AM) function and/or mycobacteria-specific alveolar CD4(+) T-cell responses observed in HIV-infected ART-naive adults. OBJECTIVES: To determine whether ART was associated with improvement in both AM function, assessed by phagosomal proteolysis, and alveolar CD4(+) T-cell responses to Mycobacterium in HIV-infected individuals. METHODS: Peripheral blood was drawn and bronchoalveolar lavage (BAL) performed on healthy, 35 HIV-uninfected, 25 HIV-infected ART-naive, and 50 HIV-infected ART-treated asymptomatic adults. Phagosomal proteolysis of AM was assessed with fluorogenic beads. Mycobacteria-specific CD4(+) T-cell responses were measured by intracellular cytokine staining. MEASUREMENTS AND MAIN RESULTS:HIV-infected adults on ART exhibited lower plasma HIV viral load and higher blood CD4(+) T-cell count than ART-naive adults. AM proteolysis and total mycobacteria-specific Th1 CD4(+) T-cell responses in individuals on ART for greater than or equal to 4 years were similar to HIV-uninfected control subjects but those on ART for less than 4 years had impaired responses. Total influenza-specific alveolar Th1 CD4(+) T-cell responses were intact in all individuals receiving ART. In contrast, BAL and blood mycobacteria-specific polyfunctional CD4(+) T-cell responses were impaired in adults on ART irrespective of duration. CONCLUSIONS: AM and mycobacteria-specific alveolar CD4(+) T-cell responses in HIV-infected adults on ART for less than 4 years are impaired and may partly explain the high risk of TB in HIV-infected individuals on ART. Strategies to augment ART to improve lung immune cell function and reduce the high incidence of TB in HIV-infected adults who initiate ART should be investigated.
Entities:
Keywords:
ART; HIV; Mycobacterium tuberculosis; T cells; macrophages
Authors: Donatella Ciuffreda; Denis Comte; Matthias Cavassini; Emiliano Giostra; Leo Bühler; Monika Perruchoud; Markus H Heim; Manuel Battegay; Daniel Genné; Beat Mulhaupt; Raffaele Malinverni; Carl Oneta; Enos Bernasconi; Martine Monnat; Andreas Cerny; Christian Chuard; Jan Borovicka; Gilles Mentha; Manuel Pascual; Jean-Jacques Gonvers; Giuseppe Pantaleo; Valérie Dutoit Journal: Eur J Immunol Date: 2008-10 Impact factor: 5.532
Authors: Kathleen M Neuzil; Christopher S Coffey; Ed F Mitchel; Marie R Griffin Journal: J Acquir Immune Defic Syndr Date: 2003-11-01 Impact factor: 3.731
Authors: Emily K Forbes; Clare Sander; Edward O Ronan; Helen McShane; Adrian V S Hill; Peter C L Beverley; Elma Z Tchilian Journal: J Immunol Date: 2008-10-01 Impact factor: 5.422
Authors: Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French Journal: Vaccine Date: 2008-08-15 Impact factor: 3.641
Authors: Martin W G Brinkhof; Andrew Boulle; Ralf Weigel; Eugène Messou; Colin Mathers; Catherine Orrell; François Dabis; Margaret Pascoe; Matthias Egger Journal: PLoS Med Date: 2009-04-28 Impact factor: 11.069
Authors: Thomas J Scriba; Barbara Kalsdorf; Deborah-Ann Abrahams; Fatima Isaacs; Jessica Hofmeister; Gillian Black; Hisham Y Hassan; Robert J Wilkinson; Gerhard Walzl; Sebastian J Gelderbloem; Hassan Mahomed; Gregory D Hussey; Willem A Hanekom Journal: J Immunol Date: 2008-02-01 Impact factor: 5.422
Authors: Samantha M Yeligar; Janine M Ward; Frank L Harris; Lou Ann S Brown; David M Guidot; Sushma K Cribbs Journal: AIDS Res Hum Retroviruses Date: 2017-04-24 Impact factor: 2.205
Authors: Leopoldo N Segal; Jose C Clemente; Yonghua Li; Chunhai Ruan; Jane Cao; Mauricio Danckers; Alison Morris; Sarah Tapyrik; Benjamin G Wu; Philip Diaz; Gregory Calligaro; Rodney Dawson; Richard N van Zyl-Smit; Keertan Dheda; William N Rom; Michael D Weiden Journal: Cell Host Microbe Date: 2017-03-30 Impact factor: 21.023
Authors: Rubina Bunjun; Fidilia M A Omondi; Mohau S Makatsa; Roanne Keeton; Jerome M Wendoh; Tracey L Müller; Caryn S L Prentice; Robert J Wilkinson; Catherine Riou; Wendy A Burgers Journal: J Immunol Date: 2021-08-13 Impact factor: 5.422
Authors: Collin R Diedrich; Jennifer O'Hern; Maximiliano G Gutierrez; Nafiesa Allie; Patricia Papier; Graeme Meintjes; Anna K Coussens; Helen Wainwright; Robert J Wilkinson Journal: J Infect Dis Date: 2016-07-26 Impact factor: 5.226
Authors: Chikondi Peno; Dominic H Banda; Ndaru Jambo; Anstead M Kankwatira; Rose D Malamba; Theresa J Allain; Daniela M Ferreira; Robert S Heyderman; David G Russell; Henry C Mwandumba; Kondwani C Jambo Journal: J Infect Date: 2017-11-29 Impact factor: 6.072
Authors: Davide Pisu; Lu Huang; Vipin Narang; Monique Theriault; Gabrielle Lê-Bury; Bernett Lee; Agnes E Lakudzala; David T Mzinza; David V Mhango; Steven C Mitini-Nkhoma; Kondwani C Jambo; Amit Singhal; Henry C Mwandumba; David G Russell Journal: J Exp Med Date: 2021-07-22 Impact factor: 14.307